Título Abreviado: ECM 22/1809
Investigador Principal: María Belén Vidriales Vicente
Código EUDRACT: 2019-004134-42
Código Identificativo: ECI2022/0104


Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S Maintenance Therapy Compared to Best Available Therapy in Acute Myeloid Leukemia Patients Who Have Achieved Complete Remission After Second-Line Salvage Therapy

Estado: ACTIVO

Pin It en Pinterest